In-Use Test With a Cosmetic Product to Treat Pruritus

Dr. August Wolff

Status

Completed

Conditions

Pruritus

Treatments

Other: WO 3308 cosmetic product for topical use

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT03477058

LPC-17/2016

Details and patient eligibility

About

The aim of the study is to evaluate the cosmetic features of the product WO 3308 by means of a questionnaire in an interview situation after two weeks of product treatment, giving special consideration to the cosmetic performance, efficacy and skin compatibility and with special focus on the reduction of pruritus. Additionally the tolerance will be evaluated by a dermatologist.

Enrollment

55 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

age: ≥ 18 years
sex: approx. 25% to 50% male and 50% to 75% female
with acute pruritus (lasts less than 6 weeks) or chronic pruritus (lasts longer than 6 weeks): max. 50% with acute pruritus and at least 50% with chronic pruritus

Exclusion criteria

any deviation from the above-mentioned criteria
known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
topical medication in the test area within 1 month prior to study start
systemic medication with antibiotics within 2 weeks prior to starting of the study
change in the medication with anti-inflammatory agents within 2 weeks prior to starting the study
systemic medication with immunomodulators (immunsuppressive drugs in the course of a transplantation) and/or chemotherapeutic agents within 4 weeks prior to starting the study
neurodermatitis (atopic dermatitis)
pregnancy and period of breastfeeding